{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:59:37Z","timestamp":1781819977262,"version":"3.54.5"},"reference-count":78,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32060180"],"award-info":[{"award-number":["32060180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160304"],"award-info":[{"award-number":["82160304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:p>\n                    Ethambutol (EMB) serves as a critical first-line antimycobacterial agent pivotal in the management of\n                    <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                    . The emergence of resistance to EMB, primarily driven by mutations in the\n                    <jats:italic toggle=\"yes\">embB<\/jats:italic>\n                    gene, constitutes a formidable challenge to global tuberculosis (TB) eradication efforts. This meta-analysis followed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines and synthesized data from multiple databases, including PubMed, Embase, MEDLINE, Web of Science, and Elsevier Science, through August 2024. The selection criteria targeted studies reporting the prevalence and patterns of EMB resistance, utilizing both phenotypic and genotypic diagnostic methods. Data were extracted using Microsoft Excel, and statistical analyses were performed with Stata 17.0. Study heterogeneity was evaluated using the\n                    <jats:italic toggle=\"yes\">I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    statistic and Cochran\u2019s Q test. A random-effects model using the DerSimonian\u2013Laird method estimated the pooled prevalence of EMB resistance, with subgroup analyses distinguishing new cases from those with a treatment history exceeding 1 month. Fifty-one studies (34,215 isolates; 2,776 EMB-resistant) were included. The pooled prevalence of EMB resistance was 10% (95% confidence interval [CI]: 8\u201312%;\n                    <jats:italic toggle=\"yes\">I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    = 92.99%), with substantial regional variation (Africa [15.56%] vs. Southeast Asia [6.60%]). Among multidrug-resistant TB patients, EMB resistance was 54% (95% CI: 45\u201363%) and reached 68% (95% CI: 65\u201372%) in the Eastern Mediterranean; previously treated patients had higher resistance than new cases (31% vs. 13%). Only 12 studies reported codon-specific\n                    <jats:italic toggle=\"yes\">embB<\/jats:italic>\n                    data eligible for pooling, with\n                    <jats:italic toggle=\"yes\">embB306<\/jats:italic>\n                    most frequently reported and notable regional gaps for\n                    <jats:italic toggle=\"yes\">embB406\/497<\/jats:italic>\n                    (e.g., Americas ND; Europe lacking 406\/497). The study identifies substantial regional variations in EMB resistance and the prevalence of specific\n                    <jats:italic toggle=\"yes\">embB<\/jats:italic>\n                    mutations. However, uneven regional representation (particularly limited data from Africa and the Americas) may affect the precision of global estimates. Enhancing diagnostic accuracy through molecular methods and developing regional surveillance systems are essential for effective management of EMB-resistant TB. Future research should prioritize comprehensive genomic analyses to identify novel resistance mutations and advance diagnostic methodologies. Future studies should adopt whole-genome sequencing and standardized codon-level reporting to enable comprehensive mutation profiling and improve comparability across surveillance systems.\n                  <\/jats:p>","DOI":"10.1177\/10766294261448630","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:58:51Z","timestamp":1778158731000},"page":"295-304","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global Status of Ethambutol Resistance in\n                    <i>Mycobacterium tuberculosis<\/i>\n                    Clinical Isolates: An Updated Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"32","author":[{"given":"Xiting","family":"Dai","sequence":"first","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."},{"name":"Clinical Laboratory, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxin","family":"Wu","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Ma","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Peng","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyi","family":"Luo","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2874-6570","authenticated-orcid":false,"given":"Fukai","family":"Bao","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."},{"name":"Research Center, Baoshan People\u2019s Hospital, Baoshan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liu","sequence":"additional","affiliation":[{"name":"Yunnan Province Key Laboratory of Children\u2019s Major Diseases Research, Department of Pathogen Biology and Immunology, Faculty of Basic Medicine, Kunming Medical University, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00301-3"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.2.326-336.2000"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.05343-0"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00359-7"},{"issue":"4","key":"e_1_3_4_6_1","first-page":"382","article-title":"Multidrug-resistant tuberculosis: Epidemiology, risk factors and case finding","volume":"14","author":"Caminero JA","year":"2010","unstructured":"5.Caminero JA. Multidrug-resistant tuberculosis: Epidemiology, risk factors and case finding. Int J Tuberc Lung Dis 2010;14(4):382\u2013390.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2008.00400.x"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics3030317"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02713-13"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2004.04.001"},{"issue":"4","key":"e_1_3_4_11_1","first-page":"180","article-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB): Problems and solutions","volume":"57","author":"Prasad R","year":"2010","unstructured":"10.Prasad R. Multidrug and extensively drug-resistant TB (M\/XDR-TB): Problems and solutions. Indian J Tuberc 2010;57(4):180\u2013191.","journal-title":"Indian J Tuberc"},{"issue":"5","key":"e_1_3_4_12_1","first-page":"565","article-title":"Mycobacteria: Laboratory methods for testing drug sensitivity and resistance","volume":"29","author":"Canetti G","year":"1963","unstructured":"11.Canetti G, , Froman S, , Grosset J, et al. Mycobacteria: Laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963;29(5):565\u2013578.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_4_13_1","volume-title":"Practical manual on tuberculosis laboratory strengthening, 2022 update","author":"Organization WH","year":"2022","unstructured":"12.Organization WH. Practical manual on tuberculosis laboratory strengthening, 2022 update. Geneva, Switzerland: WHO 2022."},{"key":"e_1_3_4_14_1","volume-title":"JBI Manual for Evidence Synthesis","author":"Munn Z","year":"2019","unstructured":"13.Munn Z, , Moola S, , Lisy K, et al. Chapter 5: Systematic Reviews of Prevalence and Incidence. JBI Manual for Evidence Synthesis. 2019."},{"key":"e_1_3_4_15_1","unstructured":"14.Institute JB. Critical-appraisal-tools 2020. [cited 2024]. Available from: https:\/\/jbi.global\/critical-appraisal-tools"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"issue":"4","key":"e_1_3_4_17_1","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel N","year":"1959","unstructured":"16.Mantel N, , Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22(4):719\u2013748.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2022.102184"},{"issue":"2","key":"e_1_3_4_19_1","first-page":"160","article-title":"Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam","volume":"10","author":"Quy HT","year":"2006","unstructured":"18.Quy HT, , Buu TN, , Cobelens FG, et al. Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006;10(2):160\u2013166.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108789"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13285"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(96)00335-4"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.1.148"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(01)00298-9"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1067\/mic.2001.110779"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00353-9"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.05.010"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2006.05.004"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.03.012"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(08)60145-X"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2009.04.002"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.09.021"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2009.09.001"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.11.027"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1684-1182(10)60045-X"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03351.x"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm054"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2011.12.015"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2012.05.005"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2012.07.001"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.03.025"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2012.08.004"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2013.02.035"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2013.02.005"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2013.03.003"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2013.03.002"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.05.020"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.08.023"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2015.02.041"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2015.07.004"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jegh.2015.01.002"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.11.008"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2015.12.009"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2015.10.008"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcdt.2016.11.002"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2017.04.008"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2016.06.007"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.06.011"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.11.015"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2017.10.003"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2017.05.008"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2018.08.018"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2021.102063"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2022.01.015"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.09.014"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2023.101192"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2023.102411"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2022.08.004"},{"key":"e_1_3_4_69_1","volume-title":"Treatment of Tuberculosis: Guidelines. WHO Guidelines Approved by the Guidelines Review Committee","author":"Organization WH","year":"2010","unstructured":"68.Organization WH. Treatment of Tuberculosis: Guidelines. WHO Guidelines Approved by the Guidelines Review Committee. 4th ed. Geneva 2010.","edition":"4"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2022.115856"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0650-x"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1906-3"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2019.05.033"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12359"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.10.017"},{"key":"e_1_3_4_76_1","first-page":"1415","article-title":"Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line","author":"Rossini NA-O","year":"2023","unstructured":"75.Rossini NA-O, , Dias MA-O. Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line. Genet Mol Biol 2023:1415\u20134757.","journal-title":"Genet Mol Biol"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1442987"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116245"},{"key":"e_1_3_4_79_1","unstructured":"78.Organization WH. Anti-tuberculosis drug resistance in the world: Fourth global report. 2008."}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10766294261448630","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10766294261448630","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10766294261448630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:46:29Z","timestamp":1781819189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10766294261448630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"alternative-id":["10.1177\/10766294261448630"],"URL":"https:\/\/doi.org\/10.1177\/10766294261448630","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]}}}